Metamark Genetics announced today the appointment of three new board members, increasing the number of total members to seven.
The new members include, Gregory Critchfield, former president of Myriad Genetics Laboratories; Mansoor Raza Mirza, chief oncologist at the Finsen Center of Copenhagen University Hospital in Denmark; and Slava Smolokowski, founder of the European energy trading business Mercuria Energy Group.
OncoMethylome this week announced the appointment of Melissa Thompson as its new VP of regulatory affairs and quality assurance, and Christopher Thibodeau as its VP of commercial operations.
Thompson brings to OncoMethylome prior experience providing consultative services in diagnostics to Johnson & Johnson, Wyeth, Inverness, Affymetrix, and others. She has seen multiple products through US Food and Drug Administration approval, and has a background in clinical research and trial design.
Thibodeau comes to OncoMethylome from Agendia, where he was director of marketing. He has also held various positions in sales and marketing at Numira Biosciences, US Labs, and Ventana Medical.
The Association of American Cancer Institutes will present the AACI Distinguished Scientist Award to Mary-Claire King, professor of genome sciences and medicine, at the University of Washington, on October 4, during the association's annual meeting in Chicago.
"The award recognizes King's extraordinary scientific accomplishments and contributions to the cancer center and cancer research communities," AACI said in a statement announcing the award. King is best known for her identification of the BRCA 1 gene conferring heightened risk of developing hereditary breast cancer; for demonstrating in her 1973 PhD dissertation that humans and chimpanzees are 99 percent similar at the genetic level; and for showing that human remains can be identified through DNA sequencing.
AACI's annual meeting will be held Oct. 3-5, at The Westin Chicago River North.